Alzheimer's Drug Discovery Foundation Invites LOIs for Prevention Pipeline Program. Letters of Intent Due: February 5, 2011. Up to $3,000,000 will e awarded for clinical trials based on stage and scope of research.
Awards will be made in support of studies of cognitive symptoms due to health conditions, comparative effectiveness research, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline.